NxStage Medical CEO and leadership

Bill Valle is Executive Vice President of Fresenius Medical Care North America (FMCNA) and President of Fresenius Medical Services (FMS), the largest division of FMCNA. He is responsible for the successful management of more than 2,150 outpatient facilities, 1,400 inpatient programs, and 800 home dialysis programs across the U.S. Approximately 165,000 dialysis patients receive life-sustaining dialysis therapy in these facilities. Bill previously served as President of Fresenius Medical Care Integrated Renal Services. In that capacity, he led several of the organization’s vital business functions, integrating them into a high performance renal network that can improve the outcomes and reduce the costs of managing renal disease. These include Fresenius Vascular Care, FreseniusRx, Spectra Laboratories, FMS Business Development, FMS Inpatient Services and FMS Real Estate and Construction Services. Prior to joining FMCNA, Bill had 22 years of experience in the dialysis industry, serving in executive roles in sales, marketing and business development, as well as ownership in several private dialysis centers.

Allan Collins works at NXSTAGE MEDICAL, INC. and a Chief Medical Officer at NXSTAGE MEDICAL, INC. and is based in Minneapolis, Minnesota.

Thomas 'Tom' Shea is a Senior VP:Manufacturing Ops/COO at NXSTAGE MEDICAL, INC.. He has experience at Jabil. Thomas attended Bryant University and University of Massachusetts Boston.

Bill Valle is Executive Vice President of Fresenius Medical Care North America (FMCNA) and President of Fresenius Medical Services (FMS), the largest division of FMCNA. He is responsible for the successful management of more than 2,150 outpatient facilities, 1,400 inpatient programs, and 800 home dialysis programs across the U.S. Approximately 165,000 dialysis patients receive life-sustaining dialysis therapy in these facilities. Bill previously served as President of Fresenius Medical Care Integrated Renal Services. In that capacity, he led several of the organization’s vital business functions, integrating them into a high performance renal network that can improve the outcomes and reduce the costs of managing renal disease. These include Fresenius Vascular Care, FreseniusRx, Spectra Laboratories, FMS Business Development, FMS Inpatient Services and FMS Real Estate and Construction Services. Prior to joining FMCNA, Bill had 22 years of experience in the dialysis industry, serving in executive roles in sales, marketing and business development, as well as ownership in several private dialysis centers.